BIVDA Press Releases

08Jul

BIVDA, ABPI and CRUK release briefing on new arrangements for commissioning and funding of six molecular diagnostic tests for cancer

BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commissioning and funding of six molecular diagnostic tests for cancer in the NHS in England for 2016/17. 

It aims to provide NHS staff – be they commissioner or hospital provider financial staff, clinicians and pathology staff – with a clear understanding how the new funding arrangements for these tests in 2016/17 will operate to support timely and appropriate patient access. 

To read the full briefing, click here. For more information, contact BIVDA Chief Executive, Doris-Ann Williams.

Related

Statement from BIVDA Chief Executive on COVID-19 Testing Capacity

Please find below a statement from BIVDA Chief Executive Doris-Ann Williams regarding the new plans ...

Read More >

BIVDA Launches Vision for Increasing Access to Molecular Diagnostics

A new report from the British In Vitro Diagnostics Association (BIVDA) has called for NHS England to...

Read More >

BIVDA's response to the 2019 General Election result

Commenting on the result of the General Election, BIVDA’s Chief Executive Doris-Ann Williams MBE sa...

Read More >

BIVDA Unveils New Website

The British In Vitro Diagnostics Association (BIVDA) has today unveiled its new website including a ...

Read More >

Member Press Release - NHSEI SBRI Healthcare grant for Psyros’ rapid, ultra-sensitive test for heart attack marker

NHSEI SBRI Healthcare grant for Psyros’ rapid, ultra-sensitive test for heart attack marker&nb...

Read More >

Member Press Release - UK COVID-19 rapid antibody tests approved for professional use

The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer lead...

Read More >